APRI Short Information, Apricus Biosciences Inc.

Twenty Trading Day Totals
Total Shorted Volume	1,931,956
Total Actual Volume	11,127,057

Averages
Average Short Volume	96,598
Average Short Percentage	52.01%

Is there a APRI Short Squeeze or Breakout about to happen?

See the APRI Short Analysis for free Sign up or Login

Stock Date	Open Price	Close Price	High	Low	Total Volume	Short Volume	Short Percentage
2019-01-23	0.23	0.22	0.23	0.2069	1,101,864	321,578	73.7175
2019-01-22	0.2397	0.2222	0.2397	0.213	1,289,707	395,120	82.3901
2019-01-18	0.267	0.2381	0.267	0.2311	690,440	194,174	93.5440
2019-01-17	0.263	0.26	0.275	0.25	452,786	48,293	74.0724
2019-01-16	0.2666	0.264	0.27	0.25	323,804	15,889	48.7617
2019-01-15	0.28	0.27	0.28	0.2519	623,097	61,675	44.6665
2019-01-14	0.27	0.2609	0.2731	0.2506	311,797	17,347	46.7360
2019-01-11	0.231	0.27	0.2748	0.225	571,221	22,002	14.3901
2019-01-10	0.24	0.2359	0.25	0.23	196,162	56,821	59.4710
2019-01-09	0.2488	0.242	0.26	0.2301	415,418	43,120	44.5248
2019-01-08	0.2609	0.237	0.2698	0.237	507,682	90,172	52.8756
2019-01-07	0.25	0.2604	0.28	0.24	677,546	113,455	44.1612
2019-01-04	0.2395	0.235	0.252	0.22	648,053	89,010	35.5782
2019-01-03	0.24	0.226338	0.249	0.2174	646,953	167,593	75.9064
2019-01-02	0.205	0.241	0.25	0.1851	1,174,124	96,611	30.8012
2018-12-31	0.21	0.195	0.21	0.1851	436,764	25,476	19.7254
2018-12-28	0.19	0.195	0.208	0.185	352,967	37,961	35.9728
2018-12-27	0.2087	0.19	0.2087	0.1831	247,309	52,140	42.3022
2018-12-26	0.19	0.1871	0.21	0.1851	311,275	52,329	49.5981
2018-12-24	0.21	0.189	0.2111	0.18	148,088	31,190	71.0252

Stock Information

Apricus Biosciences Inc. Company Name:

APRI Stock Symbol:

NASDAQ Market:

Apricus Biosciences Inc. Website:

APRI Short Information, Apricus Biosciences Inc.

Get APRI Alerts

News, Short Squeeze, Breakout and More Instantly...

APRI - Apricus Biosciences Reminds Shareholders to Vote Before the Special Meeting on December 14, 2018

Seeking Shareholder Approval for Proposed Merger with Seelos Therapeutics, Inc. SAN DIEGO, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq: APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, reminds shareholders to vote by...
APRI - Apricus Biosciences Provides Corporate Update and Third Quarter 2018 Financial Results

Company Merger with Seelos Therapeutics, Inc. Expected to Close in Fourth Quarter 2018 Apricus Shareholders Expected to Own ~15% of Estimated $94 Million Combined Company Valuation at Closing SAN DIEGO, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a bioph...